Skip to main content

Advertisement

SpringerLink
Log in

Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

New treatment strategies for prostate cancer have recently been developed, but multiple malignancies remain a major concern. The aim of this study was to evaluate the characteristics of multiple malignancies and to analyze the risk of secondary malignancies after radiotherapy for prostate cancer.

Methods

From 2000 to 2011, 150 patients with prostate cancer were treated with curative radiotherapy in our department. Patient age range was 54–92 years (median, 70 years), and the follow-up period was 4–142 months (median, 48 months). The incidence of multiple primary cancers was compared with the estimated incidence.

Results

A total of 147 patients (98 %) survived more than 12 months (12–142 months; median, 48 months); 20/150 patients (13 %) died within 10 years. Cause of death was recurrent prostate cancer in 11 patients, other primary malignancies in 7 patients, and cardiovascular disease in 2 patients. Multiple primary cancers were present in 26 of 150 patients (17 %), including 16 subsequent malignancies (11 %) with latent periods of 13–83 months (median, 43 months). The subsequent non-prostate malignancies were lung cancer in 4 patients, urinary bladder or ureter cancer in 4, stomach cancer in 3, malignant lymphoma in 2, and other in 3. Analysis of the observed incidence of secondary malignancies compared with the estimated incidence in the general population revealed a higher incidence of ureter cancer and malignant lymphoma.

Conclusion

Close attention should be paid to secondary malignancies after radiotherapy for prostate cancer, including malignancies occurring within 5 years, which could be attributable to radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bostrom PJ, Soloway MS (2007) Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? Eur Urol 52(4):973–982

    Article  PubMed  Google Scholar 

  2. Mariotto AB, Rowland JH, Ries LA et al (2007) Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 16(3):566–571

    Article  PubMed  Google Scholar 

  3. Tubiana M (2009) Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91(1):4–15

    Article  PubMed  Google Scholar 

  4. Berrington de Gonzalez A, Curtis RE, Kry SF et al (2011) Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12(4):353–360

    Article  PubMed  Google Scholar 

  5. Liauw SL, Sylvester JE, Morris CG et al (2006) Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 66(3):669–673

    Article  PubMed  Google Scholar 

  6. Moon K, Stukenborg GJ, Keim J et al (2006) Cancer incidence after localized therapy for prostate cancer. Cancer (Phila) 107(5):991–998

    Article  Google Scholar 

  7. Baxter NN, Tepper JE, Durham SB et al (2005) Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 128(4):819–824

    Article  PubMed  Google Scholar 

  8. Brenner DJ, Curtis RE, Hall EJ et al (2000) Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer (Phila) 88(2):398–406

    Article  CAS  Google Scholar 

  9. Spratt DE, Pei X, Yamada J et al. (2012) Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. Epub ahead of print

  10. NCCN Clinical Practice Guidelines in Oncology (2004) Prostate cancer v1. 2004. http://www.nccn.org/

  11. Matsuda T, Marugame T, Kamo K et al (2012) Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 42:139–147

    Article  PubMed  Google Scholar 

  12. Kry SF, Salehpour M, Followill DS et al (2005) The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62(4):1195–1203

    Article  PubMed  Google Scholar 

  13. Sakai K, Kitamura T, Hinata H et al. (1986) Second cancers following radiotherapy of malignant tumors. The second mail survey in Japan. Nihon Igaku Hoshasen Gakkai Zasshi 46(6):811–818

    Google Scholar 

  14. Travis LB, Curtis RE, Storm H et al (1997) Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 89(19):1429–1439

    Article  CAS  PubMed  Google Scholar 

  15. Bermejo JL, Sundquist J, Hemminki K (2009) Bladder cancer in cancer patients: population-based estimates from a large Swedish study. Br J Cancer 101(7):1091–1099

    Article  PubMed Central  PubMed  Google Scholar 

  16. Schumacher JR, Witt WP, Palta M et al (2012) Cancer screening of long-term cancer survivors. J Am Board Fam Med 25(4):460–469

    Article  PubMed Central  PubMed  Google Scholar 

  17. Cheng HY, Chu CH, Chang WH et al (2005) Clinical analysis of multiple primary malignancies in the digestive system: a hospital-based study. World J Gastroenterol 11(27):4215–4219

    PubMed  Google Scholar 

  18. Bhojani N, Capitanio U, Suardi N et al (2010) The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys 76(2):342–348

    Article  PubMed  Google Scholar 

  19. Arlen M, Higinbotham NL, Huvos AG et al (1971) Radiation-induced sarcoma of bone. Cancer (Phila) 28(5):1087–1099

    Article  CAS  Google Scholar 

  20. Warren S, Gates O (1932) Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer 16:1358–1414

    Google Scholar 

  21. Wiklund TA, Blomqvist CP, Raty J et al (1991) Postirradiation sarcoma. Analysis of a nationwide cancer registry material. Cancer (Phila) 68(3):524–531

    Article  CAS  Google Scholar 

  22. Chaturvedi AK, Engels EA, Gilbert ES et al (2007) Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 99(21):1634–1643

    Article  PubMed  Google Scholar 

  23. Jeremic B, Shibamoto Y, Acimovic L et al (2001) Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone. J Clin Oncol 19(4):1056–1063

    CAS  PubMed  Google Scholar 

  24. Smith J, O’Connell RS, Huvos AG et al (1980) Hodgkin’s disease complicated by radiation sarcoma in bone. Br J Radiol 53(628):314–321

    Article  CAS  PubMed  Google Scholar 

  25. Nishimura Y, Sakai K, Kitamura T et al (1986) Radiation-induced cancers following radiotherapy of benign diseases: the second mail survey in Japan. Gan To Kagaku Ryoho 13:1492–1498

    CAS  PubMed  Google Scholar 

  26. Bednarz B, Athar B, Xu XG (2010) A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models. Med Phys 37(5):1987–1994

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

No author has any conflict of interest.

Author information

Authors and Affiliations

  1. Department of Radiology, Nara Hospital, Kinki University, 1248-1 Otoda, Ikoma, 630-0293, Japan

    Kaoru Okajima, Hitoshi Tatebe, Kazuhisa Fujiwara, Keiji Hiroi & Hirokazu Hasegawa

  2. Department of Radiation Oncology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, 589-8511, Japan

    Kazuki Ishikawa, Tomohiro Matsuura & Yasumasa Nishimura

Authors
  1. Kaoru Okajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuki Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomohiro Matsuura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hitoshi Tatebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazuhisa Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keiji Hiroi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hirokazu Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yasumasa Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kaoru Okajima.

About this article

Cite this article

Okajima, K., Ishikawa, K., Matsuura, T. et al. Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy. Int J Clin Oncol 18, 1078–1084 (2013). https://doi.org/10.1007/s10147-012-0496-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-012-0496-3

Keywords

Search

Navigation